Roy Gray

Roy Gray currently serves as the Vice President of Nonclinical Development at Sudo Biosciences, a position held since April 2024. Prior to this role, Roy Gray had a diverse career in the biopharmaceutical sector, including positions as an In Vitro Pharmacologist at MedImmune from January 2009 to June 2013, and as a Neuropharmacologist and Electrophysiologist at GSK from May 2001 to October 2008. Additional experience includes leadership roles such as Executive Director of Discovery & Preclinical Research at Kanna Health and Director of Discovery & Preclinical Research at PsiClone Ltd. Roy Gray also worked at Heptares from June 2013 to November 2014 and was involved with GW Pharmaceuticals plc from December 2014 to December 2021.